Krystal Biotech, Inc. Common Stock KRYS
i
Market dataready · fetched 2026-11-06T21:48:15.233Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T21:26:39.699940687Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-06T21:48:15.075014+00:00
Krystal Biotech, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 326.52 | 45.6% | 9.5% | 278.72 | 49.9% | 8.5% |
| 25Δ | 319.14 | 40.8% | 7.2% | 283.68 | 48.0% | 7.2% |
| 30Δ | 315.61 | 41.2% | 6.4% | 288.62 | 45.2% | 5.8% |
| 35Δ | 312.08 | 41.5% | 5.6% | 292.43 | 44.0% | 5.0% |
| 40Δ | 308.70 | 41.7% | 4.8% | 295.80 | 43.5% | 4.3% |
| 45Δ | 305.55 | 41.7% | 4.2% | 299.17 | 43.0% | 3.6% |
| 50Δ | 302.39 | 41.7% | 3.6% | 302.45 | 42.9% | 3.1% |
| 55Δ | 299.19 | 41.8% | 3.1% | 305.71 | 42.9% | 2.6% |
| 60Δ | 295.85 | 42.6% | 2.7% | 308.96 | 43.0% | 2.2% |
| 65Δ | 292.52 | 43.3% | 2.3% | 312.65 | 43.2% | 1.8% |
| 70Δ | 289.00 | 43.9% | 1.9% | 316.55 | 43.6% | 1.4% |
| 75Δ | 284.95 | 44.3% | 1.5% | 320.65 | 44.0% | 1.1% |
| 80Δ | 280.90 | 44.6% | 1.2% | 326.32 | 45.2% | 0.8% |
20Δ
- Pseudo strike
- 326.52
- IV
- 45.6%
- B/E move
- 9.5%
- Pseudo strike
- 278.72
- IV
- 49.9%
- B/E move
- 8.5%
25Δ
- Pseudo strike
- 319.14
- IV
- 40.8%
- B/E move
- 7.2%
- Pseudo strike
- 283.68
- IV
- 48.0%
- B/E move
- 7.2%
30Δ
- Pseudo strike
- 315.61
- IV
- 41.2%
- B/E move
- 6.4%
- Pseudo strike
- 288.62
- IV
- 45.2%
- B/E move
- 5.8%
35Δ
- Pseudo strike
- 312.08
- IV
- 41.5%
- B/E move
- 5.6%
- Pseudo strike
- 292.43
- IV
- 44.0%
- B/E move
- 5.0%
40Δ
- Pseudo strike
- 308.70
- IV
- 41.7%
- B/E move
- 4.8%
- Pseudo strike
- 295.80
- IV
- 43.5%
- B/E move
- 4.3%
45Δ
- Pseudo strike
- 305.55
- IV
- 41.7%
- B/E move
- 4.2%
- Pseudo strike
- 299.17
- IV
- 43.0%
- B/E move
- 3.6%
50Δ
- Pseudo strike
- 302.39
- IV
- 41.7%
- B/E move
- 3.6%
- Pseudo strike
- 302.45
- IV
- 42.9%
- B/E move
- 3.1%
55Δ
- Pseudo strike
- 299.19
- IV
- 41.8%
- B/E move
- 3.1%
- Pseudo strike
- 305.71
- IV
- 42.9%
- B/E move
- 2.6%
60Δ
- Pseudo strike
- 295.85
- IV
- 42.6%
- B/E move
- 2.7%
- Pseudo strike
- 308.96
- IV
- 43.0%
- B/E move
- 2.2%
65Δ
- Pseudo strike
- 292.52
- IV
- 43.3%
- B/E move
- 2.3%
- Pseudo strike
- 312.65
- IV
- 43.2%
- B/E move
- 1.8%
70Δ
- Pseudo strike
- 289.00
- IV
- 43.9%
- B/E move
- 1.9%
- Pseudo strike
- 316.55
- IV
- 43.6%
- B/E move
- 1.4%
75Δ
- Pseudo strike
- 284.95
- IV
- 44.3%
- B/E move
- 1.5%
- Pseudo strike
- 320.65
- IV
- 44.0%
- B/E move
- 1.1%
80Δ
- Pseudo strike
- 280.90
- IV
- 44.6%
- B/E move
- 1.2%
- Pseudo strike
- 326.32
- IV
- 45.2%
- B/E move
- 0.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 47.14% | |
| 47.19% | |
| 47.47% | |
| 48.25% | |
| 48.33% | |
| 49.03% | |
| 48.83% | |
| 49.17% | |
| 49.15% | |
| 50.09% |
Biotechnology
KURA
Description unavailable
More →KYMR
Description unavailable
More →KYTX
Description unavailable
More →KZIA
Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia.
More →LBRX
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.…
More →LCTX
Description unavailable
More →